Yeomans · Handbook of experimental pharmacology 2012 · narrative review · n=?

Muscarinic receptors in brain stem and mesopontine cholinergic arousal functions.

Cited 54 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Narrative review of preclinical anatomical and mechanistic neurobiology.

PubMed 22222702 · doi:10.1007/978-3-642-23274-9_11 · record verified 2026-08-26

What was done

This narrative review synthesizes preclinical neuroanatomical and neuropharmacological literature on the distribution and behavioral functions of muscarinic receptor subtypes across brainstem and mesopontine cholinergic nuclei, specifically Ch5 (pedunculopontine tegmental nucleus), Ch6 (laterodorsal tegmental nucleus), and Ch8 (parabigeminal nucleus).

What was found

The abstract provides no quantitative data or effect sizes. It qualitatively details neuroanatomical and circuit pathways: all five muscarinic receptor subtypes are present across the brainstem, with M2 concentrated in the hindbrain. Ch5 and Ch6 neurons are activated by arousing and reward stimuli and inhibited via M2-like autoreceptors. Ascending Ch5/Ch6 projections stimulate the thalamus, basal forebrain, and orexin neurons (via M3) to promote wakefulness and attention, while activating midbrain dopamine neurons (via M5) to enhance reward-seeking, locomotion, and rodent mating vocalizations. Ch5 activation of the superior colliculus facilitates saccades and approach behaviors alongside pontine inhibition of startle reflexes. Ch8 neurons project to outer superior colliculus layers where M2 receptors associate with retinotectal terminals. Descending Ch5/Ch6 projections to the dorsal pontine reticular formation regulate M2-dependent REM sleep.

Why it matters

It maps how specific muscarinic receptor subtypes within distinct mesopontine cholinergic pathways independently coordinate core neurobehavioral functions, including wakefulness, REM sleep, motor orienting, and reward-seeking.

Limits

The abstract lacks systematic search criteria, quality appraisal, sample sizes, and quantitative outcome measures. The mechanistic and circuit findings derive predominantly from animal models and basic neurobiology, limiting direct translation to human clinical pharmacology.

Cited by